Skip to main content
News

Queen Mary announces Strategic Collaboration Agreement with Envisagenics and Cancer Research Horizons

Collaboration will leverage Envisagenics' SpliceCore® AI platform for expanded discovery and research in hematopoietic cancers

Published on:

For media information, contact:

Press Office
email: press@qmul.ac.uk
Back to top